* Its Immunix™ precision diagnostics platform leverages machine learning algorithms trained on deep biological data and broad clinical data designed to more holistically capture and illuminate the complex health states of patients. *Its proprietary NOSIS™ dataset is one of the the largest and fastest growing hybrid biomarker-clinical dataset for sepsis care. *The Sepsis ImmunoScore™ diagnostic on the Immunix™ platform has the potential to save thousands of lives and billions of dollars in healthcare spending annually. The Sepsis ImmunoScore™ is not yet approved for commercial use in the United States.